awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42086661-8DFFBF4B-FBD5-41D0-90C8-4E47B35D2359
Q42086661-8DFFBF4B-FBD5-41D0-90C8-4E47B35D2359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42086661-8DFFBF4B-FBD5-41D0-90C8-4E47B35D2359
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.
P2860
Q42086661-8DFFBF4B-FBD5-41D0-90C8-4E47B35D2359
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42086661-8DFFBF4B-FBD5-41D0-90C8-4E47B35D2359
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
08bbb41070e109b0b09c60a836e23f64310cf96e
P2860
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.